Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
9.77
-0.05 (-0.51%)
At close: Dec 5, 2025, 4:00 PM EST
9.96
+0.19 (1.94%)
After-hours: Dec 5, 2025, 7:14 PM EST
Design Therapeutics Market Cap
Design Therapeutics has a market cap or net worth of $556.54 million as of December 5, 2025. Its market cap has increased by 70.64% in one year.
Market Cap
556.54M
Enterprise Value
352.31M
1-Year Change
70.64%
Ranking
Category
Stock Price
$9.77
Market Cap Chart
Since the IPO on March 26, 2021, Design Therapeutics's market cap has decreased from $2.21B to $556.54M, a decrease of -74.77%. That is a compound annual growth rate of -25.42%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 4, 2025 | 559.38M | 60.12% |
| Dec 31, 2024 | 349.35M | 135.41% |
| Dec 29, 2023 | 148.40M | -74.10% |
| Dec 30, 2022 | 572.92M | -51.55% |
| Dec 31, 2021 | 1.18B | -46.40% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 936.68B |
| Johnson & Johnson | 494.92B |
| AbbVie | 396.55B |
| UnitedHealth Group | 293.98B |
| AstraZeneca | 282.37B |
| Novartis AG | 253.36B |
| Merck & Co. | 250.76B |
| Abbott Laboratories | 219.65B |